Recurrent lupus nephritis after kidney transplantation: A surveillance biopsy study

Annals of the Rheumatic Diseases

Volumn 69, Issue 8, 2010, Pages 1484-1487

  Norby, Gudrun E ^a   Strøm, Erik H ^a   Midtvedt, Karsten ^a   Hartmann, Anders ^a   Gilboe, Inge Margrethe ^a   Leivestad, Torbjørn ^a   Stenstrøm, Jean ^a   Holdaas, Hallvard ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID; STEROID; TACROLIMUS;

ADULT; AGED; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; CLINICAL EXAMINATION; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LABORATORY TEST; LIVING DONOR; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; BIOLOGICAL MARKERS; BIOPSY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSION; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; LUPUS COAGULATION INHIBITOR; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PROTEINURIA; RECURRENCE; RISK FACTORS;

EID: 77955433231     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.122796     Document Type: Article

References (15)

1. Adler M, Chambers S, Edwards C, et al. An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period. Rheumatology (Oxford) 2006;45:1144-7. (Pubitemid 44542106)
2. Goral S, Ynares C, Shappell SB, et al. Recurrent lupus nephritis in renal transplant recipients revisited: it is not rare. Transplantation 2003;75:651-6. (Pubitemid 36337363)
3. Weng F, Goral S. Recurrence of lupus nephritis after renal transplantation: if we look for it, will we find it? Nat Clin Pract Nephrol 2005;1:62-3.
4. Nankivell BJ, Chapman JR. Chronic allograft nephropathy: current concepts and future directions. Transplantation 2006;81:643-54.
5. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
6. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004;15:241-50.
7. Solez K, Colvin RB, Racusen LC, et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007;7:518-26.
8. Gladman D, Ginzler E, Goldsmith C, et al. Systemic lupus international collaborative clinics: development of a damage index in systemic lupus erythematosus. J Rheumatol 1992;19:1820-1.
9. Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
10. Briganti EM, Russ GR, McNeil JJ, et al. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 2002;347:103-9.
11. Cosio FG, Gloor JM, Sethi S, et al. Transplant glomerulopathy. Am J Transplant 2008;8:492-6.
12. Alba P, Bento L, Cuadrado MJ, et al. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis 2003;62:556-60. (Pubitemid 36606290)
13. Norby GE, Holme I, Fellström B, et al. Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study. Arthritis Rheum 2009;60:1060-4.
14. Sestak AL, Nath SK, Kelly JA, et al. Patients with familial and sporadic onset SLE have similar clinical profiles but vary profoundly by race. Lupus 2008;17:1004-9.
15. Abutiban F, Mokkaddam K, Ameen E, et al. Comparison between familial and sporadic systemic lupus erythematosus in Kuwaiti patients. Lupus 2009;18:86-91.